Difference between revisions of "Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5 (Q9874)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 1, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Discovery of NVP-LDE225 a potent and selective smoothened antagonist, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English) | ||
| Property / title: Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pan S
0 references
2010
0 references
ACS Med. Chem. Lett.
0 references
1
0 references
Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English)
0 references
